- JP-listed companies
- PeptiDream Inc.
- Financials
- Income before tax
PeptiDream Inc. (4587)
Market cap
¥153.7B
P/E ratio
Peptidream develops new drugs using its proprietary PDPS platform and creates radiopharmaceuticals for diagnosing and treating cancer and other diseases.
| Period End | Income before tax (Million JPY) | YoY (%) |
|---|---|---|
| Dec 31, 2025 | -5,312 | -125.43% |
| Dec 31, 2024 | 20,889 | +379.82% |
| Dec 31, 2023 | 4,353 | -46.17% |
| Dec 31, 2022 | 8,087 | +69.39% |
| Dec 31, 2021 | 4,774 | -31.56% |
| Dec 31, 2020 | 6,976 | -1087.39% |
| Dec 31, 2019 | -707 | -118.56% |
| Jun 30, 2019 | 3,807 | +20.68% |
| Jun 30, 2018 | 3,154 | +20.20% |
| Jun 30, 2017 | 2,624 | +10.63% |
| Jun 30, 2016 | 2,372 | +58.53% |
| Jun 30, 2015 | 1,496 | +574.09% |
| Jun 30, 2014 | 222 | +27.49% |
| Jun 30, 2013 | 174 | -908.05% |
| Jun 30, 2012 | -22 | -106.27% |
| Jun 30, 2011 | 343 |